Evidence map›Paper›PMID 18281672›Full record

ReviewJournal of clinical oncology : official journal of the American Society of Clinical Oncology2008

Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.

Andrew H Miller, Sonia Ancoli-Israel, Julienne E Bower, Lucile Capuron, Michael R Irwin

Open access · greenAbstract readReview
In one paragraph

Review in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 288 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
288citing papers in PubMed, 11 pooled it
24.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

288 citing papers in PubMed, 11 syntheses or guidelines pooled it, 598 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Ameliorative effects of Tai Chi on cancer-related fatigue: a meta-analysis of randomized controlled trials.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Pooled it
  8. Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Pooled it
  9. Cancer-Related Fatigue, Version 2.2015.Journal of the National Comprehensive Cancer Network : JNCCN · 2015
    Guideline
  10. Survivorship: fatigue, version 1.2014.Journal of the National Comprehensive Cancer Network : JNCCN · 2014
    Guideline
  11. Guideline
  12. Impact of a Functional Intervention with Home Follow-Up on Respiratory Symptoms and Functionality in Oncology Patients: A Randomised Clinical Trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial
  13. Trial
  14. Trial
  15. Qualitative similarities and distinctions between participants' experiences with a yoga intervention and an attention control.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Trial
  16. Trial
  17. Trial
  18. Trial
  19. Hyperarousal and Insomnia in Survivors of Cancer.International journal of behavioral medicine · 2021
    Trial
  20. Yoga therapy to reduce fatigue in cancer: effects of reminder e-mails and long-term efficacy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Trial

228 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Andrew H MillerDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Winship Cancer Institute, 1365-C Clifton Rd, 5th Floor, Atlanta, GA 30322, USA. amill02@emory.edu
Sonia Ancoli-Israel
Julienne E Bower
Lucile Capuron
Michael R Irwin
University of California, Los Angeles · USUniversity of California, San Diego · USUniversity of California System · US

Funding

ZOVIRAX CREAM TO TREAT HERPES LABIALIS IN ADOLESCENTSM01RR000827 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, R JEFFREY · 1985 to 2010
$74.3M
ZDV &3TC NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFECTED INFANTS &M01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASHINGTON, ARNOLD E. · 1985 to 2011
$43.4M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Aging: Sleep and Inflammatory Mechanisms in Depression PreventionR01AG026364 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI IRWIN, MICHAEL R · 2005 to 2015
$5.8M
Sleep and Immune Mechanisms in Rheumatoid ArthritisR01HL079955 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI IRWIN, MICHAEL R · 2006 to 2009
$3.0M
Contributions of sleep/rhythms/fatigue to chemobrainR01CA112035 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ANCOLI-ISRAEL, SONIA · 2005 to 2009
$1.8M
Post-Graduate Training Program in Psychoneuroimmunology and Mental HealthT32MH019925 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI IRWIN, MICHAEL R · 1997 to 2012
$1.7M
FATIGUE, SLEEP AND CIRCADIAN RHYTHMS IN BREAST CANCERR01CA085264 · NCI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI ANCOLI-ISRAEL, SONIA · 2000 to 2004
$1.4M
Mechanisms of Radiation Induced Fatigue in CancerK07CA090407 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BOWER, JULIENNE E · 2001 to 2006
$636k
Pathology and Treatment of Cytokine-Induced DepressionK05MH069124 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2004 to 2008
$585k
NCATS NIH HHS UL1 TR000454NCI NIH HHS CA 0014152NCI NIH HHS CA090407NCI NIH HHS CA112035NCI NIH HHS CA85264NCI NIH HHS K07 CA090407NCI NIH HHS R01 CA085264NCI NIH HHS R01 CA112035NCRR NIH HHS M01-RR00039NCRR NIH HHS M01 RR000827NCRR NIH HHS M01 RR000865NCRR NIH HHS M01-RR00865NHLBI NIH HHS HL079955NHLBI NIH HHS R01 HL079955NIA NIH HHS AG026364NIA NIH HHS R01 AG026364NIMH NIH HHS K05 MH069124NIMH NIH HHS MH069124NIMH NIH HHS T32 MH019925NIMH NIH HHS T32-MH19925PHS HHS 11IB-0034
6 · The paper itself

Abstract

Patients with cancer experience a host of behavioral alterations that include depression, fatigue, sleep disturbances, and cognitive dysfunction. These behavioral comorbidities are apparent throughout the process of diagnosis and treatment for cancer and can persist well into the survivorship period. There is a rich literature describing potential consequences of behavioral comorbidities in patients with cancer including impaired quality of life, reduced treatment adherence, and increased disease-related morbidity and mortality. Medical complications of cancer and its treatment such as anemia, thyroid dysfunction, and the neurotoxicity of cancer chemotherapeutic agents account in part for these behavioral changes. Nevertheless, recent advances in the neurosciences and immunology/oncology have revealed novel insights into additional pathophysiologic mechanisms that may significantly contribute to the development of cancer-related behavioral changes. Special attention has been focused on immunologic processes, specifically activation of innate immune inflammatory responses and their regulation by neuroendocrine pathways, which, in turn, influence CNS functions including neurotransmitter metabolism, neuropeptide function, sleep-wake cycles, regional brain activity, and, ultimately, behavior. Further understanding of these immunologic influences on the brain provides a novel conceptual framework for integrating the wide spectrum of behavioral alterations that occur in cancer patients and may reveal a more focused array of translational targets for therapeutic interventions and future research. Such developments warrant complementary advances in identification of cancer patients at risk as well as those currently suffering, including an increased emphasis on the status of behavior as a "sixth vital sign" to be assessed in all cancer patients throughout their disease encounter.

Indexed as

AnimalsBiomarkersChronotherapyCircadian RhythmCognitionCognition DisordersComorbidityCytokinesDepressionFatigueHumansHydrocortisoneInflammationNeoplasmsNeuropsychological TestsNeurosecretory SystemsBiomarkersCytokinesHydrocortisone

Identifiers

PMID18281672
PMCPMC2770012
OpenAlexW2164859678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.